Life-threatening complications of betamimetic therapy for preterm labor inhibition.
Betamimetic administration for inhibition of preterm labor can result in a number of severe complications for the mother. An understanding of clinical situations that increase the risk of complications and suggested treatment of adverse effects are discussed in this review.
D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D002545:Brain Ischemia / Q000139:chemically induced / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000503:physiopathology; D003327:Coronary Disease / Q000139:chemically induced / Q000503:physiopathology; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced / Q000503:physiopathology; D007022:Hypotension / Q000139:chemically induced / Q000503:physiopathology; D007674:Kidney Diseases / Q000139:chemically induced / Q000503:physiopathology; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced* / Q000503:physiopathology; D011249:Pregnancy Complications, Cardiovascular / Q000139:chemically induced / Q000503:physiopathology; D011654:Pulmonary Edema / Q000139:chemically induced / Q000503:physiopathology
D000318:Adrenergic beta-Agonists